TOP-177 Baseline ANTICIPATE score and response predicts liver outcome events in an 180 patient MASH cirrhosis cohort treated with resmetirom

Journal of Hepatology 2026

View at publisher

Authors: Naim Alkhouri, Rebecca A. Taub, Xiaomin Lu, Jörn M. Schattenberg, Mazen Noureddin

DOI: 10.1016/s0168-8278(26)01886-6

Cited by: 1

Fields of Study & Subjects

Liver Disease and Transplantation Drug-Induced Hepatotoxicity and Protection Liver Disease Diagnosis and Treatment